BioPharmX Announces Therapeutic Dermatology Advisory

New Post Public Reply Private Reply Replies (0) Message Board
Whos_Who
BioPharmX Announces Therapeutic Dermatology Advisory Board

MENLO PARK, Calif., Feb. 25, 2016 /PRNewswire/ -- BioPharmX Corporation (NYSE MKT: BPMX) today announced the formation of a Therapeutic Dermatology Advisory Board composed of seven dermatology thought leaders who together bring years of experience in clinical care, academia and research treating all forms of acne. They will provide strategic counsel to BioPharmX, a Silicon Valley-based specialty pharmaceutical company, as it develops products to address unmet dermatology needs.

BioPharmX is currently developing a novel topical gel formulation of minocycline, known as BPX-01, for the treatment of acne vulgaris, which has shown promise in pre-clinical studies. All advisory board members have significant experience in treating patients with acne, which the American Academy of Dermatology has declared to be the "most common skin condition in the United States," affecting 40 million to 50 million Americans.

"These distinguished advisors bring a wealth of experience in the world of acne and other dermatological conditions. Their involvement in dermatology associations and leadership in defining the standards of care offer us invaluable insight," said Anja Krammer, president and cofounder of BioPharmX.

The inaugural members of the Therapeutic Dermatology Advisory Board include:

Neal Bhatia, MD – Co-Chair
Dr. Neal Bhatia serves as the director of clinical dermatology at Therapeutics Clinical Research in San Diego. He served as interim program director and as an associate clinical professor at Harbor-UCLA Medical Center Division of Dermatology. He has a background in immunology and has interests in systemic diseases as well as mechanisms of therapy, skin cancer, acne and rosacea. He is also active at many levels in the American Academy of Dermatology, and sits on several editorial and industry advisory boards. He is an active teacher for dermatologists, primary care physicians and patients. He has published in several journals and serves as editor for "Practical Dermatology." Dr. Bhatia completed medical school at the University of Wisconsin in Madison, where he later served as an associate clinical professor and ran his private practice for nearly ten years before relocating to California.

Hilary Baldwin, MD – Co-Chair
Dr. Hilary Baldwin, a board-certified dermatologist with nearly 25 of years of experience, is medical director of the Acne Treatment and Research Center in Morristown, N.J. Previously, she was associate professor and vice chair of the dermatology department at the State University of New York, where she spent more than 20 years caring for patients, conducting clinical studies and teaching hundreds of students. She was a founding board member and president of the American Acne and Rosacea Society an alliance of dermatology medical professionals dedicated to elevating the understanding and treatment of two of the world's most common dermatological conditions. Dr. Baldwin graduated from Boston University School of Medicine with honors.

Diane S. Berson, MD
Dr. Diane Berson is an associate professor of dermatology at Weill Medical College of Cornell University and an assistant attending dermatologist at the New York-Presbyterian Hospital. She has a private practice in New York City focusing on medical, surgical and cosmetic dermatology, and cutaneous oncology. Dr. Berson is past president and a current director of the Women's Dermatologic Society. She is also a director of the American Society for Dermatologic Surgery and the Medical Council of the Skin Cancer Foundation, a trustee of the Dermatology Foundation, and a founder of The American Society of Cosmetic Dermatology and Aesthetic Surgery and the American Acne and Rosacea Society. Dr. Berson received her medical degree at New York University School of Medicine, and was chief resident in dermatology at SUNY Downstate under Dr. Alan Shalita.

James Del Rosso, DO
Dr. James Del Rosso is a board-certified dermatologist with more than 25 years of experience in dermatology and dermatologic surgery. He is an internationally recognized leader in dermatology who teaches colleagues about skin diseases and has published extensively on several topics, including acne, eczema, rosacea, psoriasis and skin cancer. He is past president of the American Acne and Rosacea Society (AARS), the American Osteopathic College of Dermatology and the American Society for Mohs Surgery. He is very active in clinical research and is editor-in chief of the Journal of Clinical and Aesthetic Dermatology. In addition, he currently serves as chair of the AARS Education Committee and as a member of the Rosacea International Study Group. He also maintains a dermatology practice in Las Vegas. Dr. Del Rosso completed his medical degree at Ohio University in Athens, Ohio.

Julie Harper, MD
Dr. Julie Harper is a board-certified dermatologist in private practice at the Dermatology and Skin Care Center of Birmingham, Ala. She is founding director of the American Acne and Rosacea Society, which was organized in 2005, and is the organization's current president-elect. Dr. Harper has a private dermatology practice that focuses on general medical, surgical and cosmetic dermatology. She is a fellow of the American Academy of Dermatology (AAD) and currently serves on the AAD's Acne Work Group, tasked with writing acne treatment guidelines. Dr. Harper is also a member of the Women's Dermatologic Society and past president of the Alabama Dermatological Society. She received her medical training at the University of Missouri-Columbia.

Diane Thiboutot, MD
Dr. Diane Thiboutot is an endowed professor of dermatology at the Pennsylvania State University College of Medicine in Hershey, PA, and the associate dean of Clinical and Translational Research Education at Penn State University College of Medicine. Listed in "The Best Doctors in America," she is a member of the AOA Honor Medical Society and is recent past president of the American Acne and Rosacea Society. In her practice at Hershey Medical Center, she specializes in the care of patients with acne and rosacea. Dr. Thiboutot directs research programs with the support from the National Institutes of Health and partners in the pharmaceutical industry. She received her medical degree and residency training in dermatology at the Pennsylvania State University College of Medicine and University Hospital.

Guy Webster, MD, PhD
Dr. Guy Webster, who has been named one of America's Best Doctors, is a clinical professor of dermatology at Thomas Jefferson University in Philadelphia and a published author. He was the founding president of the American Acne and Rosacea Society and a fellow of the Pennsylvania Academy of Dermatology and of the American Academy of Dermatology. He is also a member of the Society for Investigative Dermatology. Dr. Webster has published numerous articles in a wide variety of publications. He serves on the editorial boards of several dermatology publications. He received his Doctor of Medicine degree at the University of Pennsylvania.

http://www.prnewswire.com/news-releases/bioph...26342.html

BioPharmX Corporation (BPMX) Stock Research Links

BPMX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kenneth Smith Takes Helm for Trends Int’l Expansion

Updated Category News Views 9

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

Continue Reading
Firmable's Tech Intelligence: New Edge in B2B Sales

Updated Category News Views 7

New Era for B2B Sales Teams Once again, the B2B sales landscape is getting a jolt—especially for those who’ve been fumbling in the dark pitching to prospects without any real idea of their tech environment. With the introduction of Firmable's Tech Intelligence, those blind days just got a lot brighter. By offering detailed insights into what technologies a company is...

Continue Reading
JELD-WEN CFO Transition: Navigating Finances Amid Changes

Updated Category News Views 5

Leadership Shake-up at JELD-WEN Alright, folks, the boardroom saga over at JELD-WEN just took another spin. Samantha Stoddard, the brain behind the numbers as Chief Financial Officer, is packing her bags come mid-November. Yeah, she's off to chase new horizons outside the realm of building products, leaving a spot hotter than a New York Stock Exchange ring bell up for...

Continue Reading
Navigating the Nitty-Gritty of Cabin Rental Management

Updated Category News Views 5

The Real Elbow Grease Behind Cabin Management Ever imagined what it’d take to keep a vacation rental cabin running like a tight ship? Well, Nathan Fitts breaks it down real clear-like. The guy's seen it all in Blue Ridge, Georgia, which isn't just about scenic views—there's serious business brewing behind that cabin charm. More Than Just Fluffing Pillows Turns out,...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 9

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
ASTS Fraud Lawsuit: Investors' Chance to Step Up

Updated Category News Views 5

Investors Grapple with AST SpaceMobile's Legal Challenges When I hear 'securities fraud lawsuit,' my gut instinct as a trader is to dig deep into the grime and figure out what's lurking beneath. AST SpaceMobile, those folks aiming to shake up the satellite game, have some explaining to do. If you've been holding onto ASTS shares between March 4, 2025, and July 15, 2026,...

Continue Reading
Navigating Braces vs. Invisalign: Key Considerations

Updated Category News Views 4

Choice Between Braces and Invisalign Isn't Straightforward When you're pondering over whether to go with braces or Invisalign, it ain't just a choice you make lightly over coffee. It's a nuanced decision that hinges on a multitude of factors as highlighted by orthodontic experts Dr. Erik Higginbottom and Dr. Kyle Higginbottom from Easton, MD, featured in HelloNation's...

Continue Reading
Community Heritage Financial Declares Q3 2026 Dividend

Updated Category News Views 4

Dividend Declared Amidst Challenging Times There's nothing quite like the ringing of a cash register, and for Community Heritage Financial, Inc. (OTCID: CMHF), that's what an $0.08 per share dividend feels like. Declared for the third quarter of 2026, this payout is set to line the pockets of shareholders who made the cut by October 30, 2026. The folks waiting for their...

Continue Reading
New Chapter Recovery Garners Key Accreditations

Updated Category News Views 8

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

Continue Reading
Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Updated Category News Views 16

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...

Continue Reading

Top 5 Most Recently Viewed Articles

Jyske Bank A/S Announces Share Capital Reduction Plans

Updated Category News Views 125

Jyske Bank A/S Announces Share Capital Reduction Jyske Bank A/S has made a significant decision regarding its share capital. This comes following an extraordinary general meeting where it was confirmed that the bank will reduce its share capital by DKK 27,651,180. This reduction corresponds to a total of 2,765,118 shares, each with a nominal value of DKK 10. The approach...

Continue Reading
Blue Ridge's HomeTrust Deal Under Ademi LLP Scrutiny

Updated Category News Views 9

Ademi LLP Takes Issue with Blue Ridge Transaction There's a brewing storm out of Milwaukee, and it’s Ademi LLP that’s ready to set off the thunder. Blue Ridge Bankshares, Inc. (NYSEAM: BRBS) finds itself under the legal microscope as Ademi breaks down the nitty-gritty of its announced transaction with HomeTrust Bancshares. This isn’t just a round-table argument over...

Continue Reading
Empowering Women Entrepreneurs: Serena Williams' Bold New Initiative

Updated Category News Views 479

Revolutionizing Support for Women Entrepreneurs Serena Williams, an iconic figure in women's sports and a determined advocate for equality in business, has taken a significant step in her entrepreneurial journey by embarking on a new initiative at Reckitt, a renowned consumer health company. An Inspiring Leadership Role As the newly appointed entrepreneur-in-residence at...

Continue Reading
RocketReach Unveils Autopilot for Seamless Outreach Automation

Updated Category News Views 157

RocketReach Unveils Autopilot: A New Era in Outreach Automation RocketReach is excited to announce the launch of Autopilot, a cutting-edge sales outreach solution designed to revolutionize how businesses connect with their prospects. With Autopilot, companies can save precious time and boost the effectiveness of their campaigns, marking a significant leap in operational...

Continue Reading
Global Growth in High-Speed SerDes Transceivers Market by 2033

Updated Category News Views 188

Understanding the High-Speed SerDes Transceivers Market Growth The High-Speed SerDes Transceivers Market is experiencing a significant transformation, with projections indicating it will reach a remarkable valuation of USD 6.14 billion by 2033. This expansion is largely fueled by the surging demand for high data throughput in various technology sectors, particularly in...

Continue Reading